Revelation Biosciences, Inc. - Common Stock (REVB)
2.7100
-0.1000 (-3.56%)
NASDAQ · Last Trade: Apr 6th, 3:36 AM EDT
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · March 17, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · March 17, 2025
The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · March 17, 2025
Via Benzinga · March 17, 2025
Via Benzinga · March 17, 2025
Via Benzinga · March 14, 2025
Via Benzinga · March 14, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via Chartmill · January 28, 2025

Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · January 28, 2025

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · January 28, 2025

Via Benzinga · January 2, 2025

Via Benzinga · December 26, 2024

Via Benzinga · December 3, 2024

Revelation Biosciences shares are trading lower by 38% during Tuesday's session. The company agreed to a $4M warrant exercise, closing December 3.
Via Benzinga · December 3, 2024

Via Benzinga · November 11, 2024

Via Benzinga · November 11, 2024

Via Benzinga · August 22, 2024

Via Benzinga · August 22, 2024

Via Benzinga · August 22, 2024

Via Benzinga · August 21, 2024

Via Benzinga · August 14, 2024

REVB stock results show that Revelation Biosciences missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 9, 2024